Enobosarm: Community Protocols & Reports
Aggregated community experiences, protocols, and stacking patterns
Community-Sourced Information
The protocols and reports on this page are gathered from online communities and forums. They represent anecdotal experiences, not clinical evidence. Individual results vary significantly. This information is not medical advice and should not replace consultation with a qualified healthcare provider. Always verify dosing and safety information with peer-reviewed research before making any decisions.
For peer-reviewed dosing protocols, see the clinical dosing guide.
Browse community protocols for all 130 peptides โ
๐TL;DR
- โข4 community protocols documented
- โขEvidence level: Structured Community Data
- โขBased on 500 community reports
- โข2 stacking patterns reported
Clinical vs. Community Protocol Differences
How community-reported protocols differ from clinical research protocols.
| Aspect | Clinical Approach | Community Approach | Significance |
|---|---|---|---|
| Source and Purity | Clinical trials use pharmaceutical-grade enobosarm manufactured under GMP conditions by Veru Inc. (formerly GTx). Each batch is tested for identity, potency, and purity. | Community members primarily source enobosarm (as Ostarine/MK-2866) from online SARM vendors. Product quality varies significantly. Third-party testing by community members has found underdosed, mislabeled, or contaminated products from some vendors. | high SARM products are not FDA-regulated dietary supplements or approved drugs. Analysis studies have found that approximately 50% of SARM products sold online contain different substances or different doses than labeled. |
| Dose Selection | Phase 2 trials used 1 mg and 3 mg doses for cancer cachexia. The QUALITY trial for muscle preservation with GLP-1 used higher doses (specific dose not publicly disclosed). Clinical doses are selected based on safety and PK data. | Community doses (10-25 mg daily) are substantially higher than Phase 2 clinical doses (1-3 mg). These higher doses originate from early bodybuilding community experimentation rather than formal dose-ranging studies. | high The large gap between clinical trial doses and community-used doses means long-term safety data does not exist for the doses most commonly used. |
| Post-Cycle Therapy (PCT) | Clinical trials do not include post-cycle recovery protocols. Testosterone suppression was noted as mild and reversible in Phase 2 trials at 1-3 mg doses. | Many community members use post-cycle therapy (PCT) with SERMs such as nolvadex (tamoxifen) or clomiphene for 4 weeks after an enobosarm cycle. Opinions are split on whether PCT is necessary at typical community doses. | moderate Testosterone suppression at community doses (10-25 mg) may be more significant than at clinical doses (1-3 mg). Blood work before and after cycles is widely recommended. |
| WADA and Legal Status | Enobosarm is being developed as a prescription pharmaceutical through the FDA approval process. | Community members purchase enobosarm as a research chemical. It is banned by WADA and most sports organizations. In several countries, SARMs occupy a legal gray area. | high Enobosarm is on the WADA Prohibited List (S1.2 Other Anabolic Agents). Several athletes have received sanctions for positive ostarine tests. Legal status varies by jurisdiction. |
Compare these community approaches with published research findings.
Community Protocols
Standard Lean Mass Protocol
Popular- Route
- Oral
- Dose
- 20-25 mg
- Frequency
- Once daily
- Duration
- 8-12 weeks
Most commonly reported protocol across Reddit r/SARMs and bodybuilding forums; taken with or without food
Conservative / Beginner Protocol
Common- Route
- Oral
- Dose
- 10-15 mg
- Frequency
- Once daily
- Duration
- 6-8 weeks
Recommended as a first SARM cycle; lower dose intended to minimize suppression
Recomposition Protocol
Common- Route
- Oral
- Dose
- 15-20 mg
- Frequency
- Once daily
- Duration
- 8-10 weeks
Used at caloric maintenance or slight deficit for simultaneous fat loss and lean mass gain
GLP-1 Muscle Preservation Protocol
Niche- Route
- Oral
- Dose
- 12.5-25 mg
- Frequency
- Once daily
- Duration
- 12-16 weeks (concurrent with GLP-1 therapy)
Emerging protocol combining enobosarm with GLP-1 agonists to reduce lean mass loss during weight loss; mirrors QUALITY trial design
Stacking Patterns
Check stack compatibility and review potential side effects before combining peptides.
Unlock community dosing protocols and stacking combos
See the exact doses, routes, and schedules 500+ self-experimenters report. Free with email.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Sources
- Reddit r/SARMs|General community protocols and experience reports(accessed 2026-02-18)
- Reddit r/PEDs|SARM cycle reports and bloodwork results(accessed 2026-02-18)
- Reddit r/Peptides|Ostarine with GLP-1 discussions(accessed 2026-02-18)
Community Evidence Overview#
Enobosarm, widely known in the community as Ostarine or MK-2866, is one of the most extensively discussed selective androgen receptor modulators (SARMs) in online fitness and biohacking communities. It has been used by self-experimenters since approximately 2011, making it one of the longest-running community experiments with a SARM compound.
Community evidence for enobosarm is classified as structured-community level, reflecting the large volume of reports (500+), consistent protocol patterns, and availability of self-reported bloodwork data across multiple platforms.
Important: Enobosarm used by the community is typically sourced from research chemical vendors, not pharmaceutical manufacturers. Product quality, purity, and accurate dosing cannot be guaranteed. The community doses (10-25 mg) are substantially higher than those used in published clinical trials (1-3 mg).
Protocol Divergence#
The most significant divergence between clinical research and community use of enobosarm involves dosing. Phase 2 clinical trials studied 1 mg and 3 mg daily doses, while the community overwhelmingly uses 10-25 mg daily โ a 3 to 25-fold difference. This means that the safety profile established in clinical trials may not apply to community-used doses.
Additionally, clinical trials focused on cancer cachexia and age-related muscle loss in ill or elderly patients, while community users are predominantly healthy adults seeking body composition improvements. The risk-benefit calculation differs substantially between these populations.
Community Protocols#
The standard community protocol involves 20-25 mg of enobosarm taken orally once daily for 8-12 weeks, followed by 4 weeks of post-cycle therapy (PCT) or recovery. Beginners are typically advised to start at 10-15 mg for 6-8 weeks.
A growing niche community has emerged around using enobosarm alongside GLP-1 receptor agonists (semaglutide, tirzepatide) to preserve lean mass during weight loss. This mirrors the approach being studied in the QUALITY and PLATEAU clinical trials, though community members use research-grade enobosarm at self-selected doses.
Commonly Reported Outcomes#
Community members commonly report:
- Modest lean mass gains of 2-4 kg over an 8-12 week cycle at caloric maintenance
- Improved muscle definition and hardness, particularly when combined with resistance training
- Mild testosterone suppression (typically 20-40% reduction in total testosterone based on self-reported bloodwork)
- Minimal androgenic side effects compared to anabolic steroids
- Recovery of testosterone levels within 4-6 weeks post-cycle
Commonly reported side effects include mild headaches (first 1-2 weeks), mild testosterone suppression, and occasional joint dryness at higher doses. Liver enzyme elevations have been reported infrequently.
Important Caveats#
- Enobosarm from research chemical vendors is not quality-controlled or FDA-regulated
- Community doses are far higher than studied clinical doses
- Long-term safety data at community doses does not exist
- Enobosarm is prohibited by WADA and most athletic organizations
- Self-reported outcomes are subject to significant bias and confounding variables
Subscribe to see vendor options
Free access to verified vendor scores, pricing, and suppliers.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Explore Further
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.